-
Something wrong with this record ?
Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology
J. M. Horacek, M. Vasatova, T. Kupsa, L. Jebavy, P. Zak
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
24089084
DOI
10.5507/bp.2013.073
Knihovny.cz E-resources
- MeSH
- Leukemia, Myeloid, Acute blood drug therapy MeSH
- Protein Array Analysis MeSH
- Cytokines blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Cell Adhesion Molecules blood MeSH
- Pilot Projects MeSH
- Vascular Endothelial Growth Factor A MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS: Evaluation of serum levels of 17 cytokines and 5 adhesion molecules in patients treated for acute myeloid leukemia (AML) using biochip array technology. This approach allows multi-analytical determination from a single sample. METHODS: A total of 15 AML patients were studied. Blood samples were taken at the diagnosis (active leukemia) and at circa 6 months after completion of last chemotherapy (durable complete remission in all patients). RESULTS: Comparing cytokine and adhesion molecule levels in active leukemia and in durable complete remission, we found significant increase (P<0.01) in serum interleukin-7 (IL-7), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and significant decrease (P<0.01) in serum E-selectin. DISCUSSION: Our results indicate that serum levels of specific cytokines and adhesion molecules (IL-7, EGF, VEGF, E-selectin) are significantly altered in patients treated for AML, reflecting activity of the disease. Further investigation is needed to establish if the changes observed in the levels of these molecules could be used as a prognostic indicator of AML.
Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove Hradec Kralove
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15026682
- 003
- CZ-PrNML
- 005
- 20200211141042.0
- 007
- ta
- 008
- 150811s2013 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2013.073 $2 doi
- 035 __
- $a (PubMed)24089084
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Horáček, Jan $u Department of Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove $7 xx0040415
- 245 10
- $a Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology / $c J. M. Horacek, M. Vasatova, T. Kupsa, L. Jebavy, P. Zak
- 520 9_
- $a AIMS: Evaluation of serum levels of 17 cytokines and 5 adhesion molecules in patients treated for acute myeloid leukemia (AML) using biochip array technology. This approach allows multi-analytical determination from a single sample. METHODS: A total of 15 AML patients were studied. Blood samples were taken at the diagnosis (active leukemia) and at circa 6 months after completion of last chemotherapy (durable complete remission in all patients). RESULTS: Comparing cytokine and adhesion molecule levels in active leukemia and in durable complete remission, we found significant increase (P<0.01) in serum interleukin-7 (IL-7), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and significant decrease (P<0.01) in serum E-selectin. DISCUSSION: Our results indicate that serum levels of specific cytokines and adhesion molecules (IL-7, EGF, VEGF, E-selectin) are significantly altered in patients treated for AML, reflecting activity of the disease. Further investigation is needed to establish if the changes observed in the levels of these molecules could be used as a prognostic indicator of AML.
- 650 _2
- $a molekuly buněčné adheze $x krev $7 D015815
- 650 _2
- $a cytokiny $x krev $7 D016207
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní myeloidní leukemie $x krev $x farmakoterapie $7 D015470
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a čipová analýza proteinů $7 D040081
- 650 _2
- $a vaskulární endoteliální růstový faktor A $7 D042461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vašatová, Martina $7 xx0135924 $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Hradec Kralove
- 700 1_
- $a Kupsa, Tomáš $7 xx0267991 $u Department of Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove
- 700 1_
- $a Jebavý, Ladislav, $d 1950- $7 mzk2007408362 $u Department of Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove
- 700 1_
- $a Žák, Pavel, $d 1966- $7 mzk2006354145 $u 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 4 (2013), s. 277-279
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20150811 $b ABA008
- 991 __
- $a 20200211141436 $b ABA008
- 999 __
- $a ok $b bmc $g 1087892 $s 909718
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 157 $c 4 $d 277-279 $e 20130927 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20150811